Hagai Bergman

Last updated
Hagai Bergman
Hagai-bergman.JPG
Born (1952-04-02) April 2, 1952 (age 72)
Tel Aviv, Israel
NationalityIsraeli
EducationHebrew University of Jerusalem (B.Sc., M.Sc., M.D., Ph.D.)
Known forResearch on the basal ganglia and Parkinson's disease
Awards
  • Rothschild Prize in Life Sciences (2004)
  • EMET Prize in Life Sciences (2013)
  • International Prize for Translational Neuroscience by the Gertrud Reemtsma Foundation (2019)
Scientific career
FieldsNeuroscience, Physiology
InstitutionsHebrew University of Jerusalem

Hagai Bergman (born 1952 in Tel Aviv) is an Israeli neuroscientist best known for his work on the basal ganglia and their involvement in movement disorders, especially Parkinson's disease. He is currently the Simone and Bernard Guttman Chair in Brain Research and Professor of Physiology in the Edmond and Lily Safra Center at the Hebrew University of Jerusalem.

Contents

Early life and education

Bergman was born in 1952, in Tel Aviv, Israel. He pursued his early education in physics and mathematics at the Hebrew University of Jerusalem, where he earned a B.Sc. in 1971 and an M.Sc. in 1973 [1] . He later transitioned to medicine and physiology, earning his M.D. in 1980 and a Ph.D. in physiology in 1986 from the same institution [2] .

Career

Bergman's research has significantly advanced our understanding of the basal ganglia's function and their implications in neurological diseases. His work has contributed to the development of deep brain stimulation (DBS) as a therapeutic intervention for Parkinson's disease. Bergman's studies have provided insights into the neural mechanisms underlying motor control and the pathological processes leading to movement disorders.

Throughout his career, Bergman has received numerous awards, including the Rothschild Prize in Life Sciences in 2004, the EMET Prize in Life Sciences in 2013, the Rappaport prize in 2013, the International Prize for Translational Neuroscience by the Gertrud Reemtsma Foundation in 2019 and the Israel Prize in 2024. [3] His scientific discoveries have been covered by major international news publications including Scientific American, [4] The Times of Israel. [5]

Research contributions

Bergman's research has focused on several key areas:

His work has led to a deeper understanding of the neural circuits involved in motor control and has had a direct impact on the treatment strategies for Parkinson's disease. Bergman's pioneering studies have paved the way for novel therapeutic approaches, improving the quality of life for patients with movement disorders. While multiple works have contributed to our understanding of the basal ganglia, a key notable contribution may be seen in the paper with Thomas Wichmann and Mahlon DeLong, which was published in 1990 in Science. In it, the team lesioned the subthalamic nucleus in the MPTP primate model of Parkinson's Disease. At the time, lesions to this structure were avoided by neurosurgeons, since it was assumed these would lead to hemiballismus. [6] However, in their experiment, Bergman and colleagues could show that lesioning the subthalamic nucleus led to sudden reversal of multiple cardinal symptoms of Parkinson's Disease, such as tremor. Their study ultimately led to the application of deep brain stimulation to the structure by the team of Alim Louis Benabid and Pierre Pollak in Grenoble. Since then, deep brain stimulation has been applied in over 200,000 patients [7] and has led to significant improvements in motor function and quality of life [8] in people living with Parkinson's Disease. Beyond clinical application, the study helped to empirically prove the theoretical predictions made by the Albin-DeLong model of the basal ganglia.

Selected publications

Related Research Articles

<span class="mw-page-title-main">Substantia nigra</span> Structure in the basal ganglia of the brain

The substantia nigra (SN) is a basal ganglia structure located in the midbrain that plays an important role in reward and movement. Substantia nigra is Latin for "black substance", reflecting the fact that parts of the substantia nigra appear darker than neighboring areas due to high levels of neuromelanin in dopaminergic neurons. Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta.

<span class="mw-page-title-main">Basal ganglia</span> Group of subcortical nuclei involved in the motor and reward systems

The basal ganglia (BG) or basal nuclei are a group of subcortical nuclei found in the brains of vertebrates. In humans and other primates, differences exist, primarily in the division of the globus pallidus into external and internal regions, and in the division of the striatum. Positioned at the base of the forebrain and the top of the midbrain, they have strong connections with the cerebral cortex, thalamus, brainstem and other brain areas. The basal ganglia are associated with a variety of functions, including regulating voluntary motor movements, procedural learning, habit formation, conditional learning, eye movements, cognition, and emotion.

<span class="mw-page-title-main">Deep brain stimulation</span> Neurosurgical treatment

Deep brain stimulation (DBS) is a surgical procedure that implants a neurostimulator and electrodes which sends electrical impulses to specified targets in the brain responsible for movement control. The treatment is designed for a range of movement disorders such as Parkinson's disease, essential tremor, and dystonia, as well as for certain neuropsychiatric conditions like obsessive-compulsive disorder (OCD) and epilepsy. The exact mechanisms of DBS are complex and not entirely clear, but it is known to modify brain activity in a structured way.

<span class="mw-page-title-main">Subthalamic nucleus</span> Small lens-shaped nucleus in the brain

The subthalamic nucleus (STN) is a small lens-shaped nucleus in the brain where it is, from a functional point of view, part of the basal ganglia system. In terms of anatomy, it is the major part of the subthalamus. As suggested by its name, the subthalamic nucleus is located ventral to the thalamus. It is also dorsal to the substantia nigra and medial to the internal capsule. It was first described by Jules Bernard Luys in 1865, and the term corpus Luysi or Luys' body is still sometimes used.

Hemiballismus or hemiballism is a basal ganglia syndrome resulting from damage to the subthalamic nucleus in the basal ganglia. Hemiballismus is a rare hyperkinetic movement disorder, that is characterized by violent involuntary limb movements, on one side of the body, and can cause significant disability. Ballismus affects both sides of the body and is much rarer. Symptoms can decrease during sleep.

<span class="mw-page-title-main">Hypokinesia</span> Decreased movement due to basal ganglia dysfunction

Hypokinesia is one of the classifications of movement disorders, and refers to decreased bodily movement. Hypokinesia is characterized by a partial or complete loss of muscle movement due to a disruption in the basal ganglia. Hypokinesia is a symptom of Parkinson's disease shown as muscle rigidity and an inability to produce movement. It is also associated with mental health disorders and prolonged inactivity due to illness, amongst other diseases.

The pedunculopontine nucleus (PPN) or pedunculopontine tegmental nucleus is a collection of neurons located in the upper pons in the brainstem. It is involved in voluntary movements, arousal, and provides sensory feedback to the cerebral cortex and one of the main components of the reticular activating system. It is a potential target for deep brain stimulation treatment for Parkinson's disease. It was first described in 1909 by Louis Jacobsohn-Lask, a German neuroanatomist.

<span class="mw-page-title-main">External globus pallidus</span> Part of the globus pallidus

The external globus pallidus combines with the internal globus pallidus (GPi) to form the globus pallidus, an anatomical subset of the basal ganglia. Globus pallidus means "pale globe" in Latin, indicating its appearance. The external globus pallidus is the segment of the globus pallidus that is relatively further (lateral) from the midline of the brain.

<span class="mw-page-title-main">Internal globus pallidus</span>

The internal globus pallidus and the external globus pallidus (GPe) make up the globus pallidus. The GPi is one of the output nuclei of the basal ganglia. The GABAergic neurons of the GPi send their axons to the ventral anterior nucleus (VA) and the ventral lateral nucleus (VL) in the dorsal thalamus, to the centromedian complex, and to the pedunculopontine complex.

Ablative brain surgery is the surgical ablation by various methods of brain tissue to treat neurological or psychological disorders. The word "Ablation" stems from the Latin word Ablatus meaning "carried away". In most cases, however, ablative brain surgery does not involve removing brain tissue, but rather destroying tissue and leaving it in place. The lesions it causes are irreversible. There are some target nuclei for ablative surgery and deep brain stimulation. Those nuclei are the motor thalamus, the globus pallidus, and the subthalamic nucleus.

<span class="mw-page-title-main">Basal ganglia disease</span> Group of physical problems resulting from basal ganglia dysfunction

Basal ganglia disease is a group of physical problems that occur when the group of nuclei in the brain known as the basal ganglia fail to properly suppress unwanted movements or to properly prime upper motor neuron circuits to initiate motor function. Research indicates that increased output of the basal ganglia inhibits thalamocortical projection neurons. Proper activation or deactivation of these neurons is an integral component for proper movement. If something causes too much basal ganglia output, then the ventral anterior (VA) and ventral lateral (VL) thalamocortical projection neurons become too inhibited, and one cannot initiate voluntary movement. These disorders are known as hypokinetic disorders. However, a disorder leading to abnormally low output of the basal ganglia leads to reduced inhibition, and thus excitation, of the thalamocortical projection neurons which synapse onto the cortex. This situation leads to an inability to suppress unwanted movements. These disorders are known as hyperkinetic disorders.

<span class="mw-page-title-main">Parkinsonian gait</span> Type of gait due to Parkinsons disease

Parkinsonian gait is the type of gait exhibited by patients with Parkinson's disease (PD). It is often described by people with Parkinson's as feeling like being stuck in place, when initiating a step or turning, and can increase the risk of falling. This disorder is caused by a deficiency of dopamine in the basal ganglia circuit leading to motor deficits. Gait is one of the most affected motor characteristics of this disorder although symptoms of Parkinson's disease are varied.

David Charles is an American neurologist, professor and vice-chair of neurology, and the medical director of Telehealth at Vanderbilt University Medical Center.

<span class="mw-page-title-main">Alim Louis Benabid</span>

Alim Louis Benabid is a French-Algerian emeritus professor, neurosurgeon and member of the French Academy of Sciences, who has had a global impact in the development of deep brain stimulation (DBS) for Parkinson's disease and other movement disorders. He became emeritus professor of biophysics at the Joseph Fourier University in Grenoble in September 2007, and chairman of the board of the Edmond J. Safra Biomedical Research Center in 2009 at Clinatec, a multidisciplinary institute he co-founded in Grenoble that applies nanotechnologies to neurosciences.

Mahlon R. DeLong was an American neurologist and professor at the Medical School of Emory University. His research has advanced the understanding and treatment of Parkinson's disease, dystonia, tremor and other neurological movement disorders.

<span class="mw-page-title-main">Cortico-basal ganglia-thalamo-cortical loop</span> System of neural circuits in the brain

The cortico-basal ganglia-thalamo-cortical loop is a system of neural circuits in the brain. The loop involves connections between the cortex, the basal ganglia, the thalamus, and back to the cortex. It is of particular relevance to hyperkinetic and hypokinetic movement disorders, such as Parkinson's disease and Huntington's disease, as well as to mental disorders of control, such as attention deficit hyperactivity disorder (ADHD), obsessive–compulsive disorder (OCD), and Tourette syndrome.

<span class="mw-page-title-main">Mesencephalic locomotor region</span>

The mesencephalic locomotor region (MLR) is a functionally defined area of the midbrain that is associated with the initiation and control of locomotor movements in vertebrate species.

Jerrold Lee Vitek is an American neurologist. He is the Head of the Neurology Department, Director of the Neuromodulation Research Program, and Center Director of the University of Minnesota Udall Center of Excellence for Parkinson's Research. Vitek's clinical interests include movement disorders and evaluation for deep brain stimulation (DBS) and his current research activities focus on Parkinson's disease, dystonia, tremor and deep brain stimulation.

<span class="mw-page-title-main">Izhar Bar-Gad</span> Israeli neurophysiologist

Izhar Bar-Gad is a full professor at the Leslie and Susan Gonda Brain Research Center at Bar-Ilan University. Bar-Gad is a researcher in the field of neurophysiology and neural computation. His main areas of research are information processing in the basal ganglia in a normal state and in various pathologies, such as Parkinson's disease and Tourette's syndrome.

<span class="mw-page-title-main">Adaptive Deep Brain Stimulation</span> Neurosurgical treatment involving implantation of an adaptive neurostimularot

Adaptive Deep Brain Stimulation (aDBS), also known as Closed Loop Deep Brain stimulation (clDBS), is a neuro-modulatory technique currently under investigation for the treatment of neurodegenerative diseases.

References

  1. Horn, Andreas (2021). "#17: Hagai Bergman – The Hidden Life of the Basal Ganglia: At the Base of the Brain and Mind". Stimulating Brains: 134685172 Bytes. doi:10.6084/M9.FIGSHARE.17283920.
  2. Bergman, Hagai (2021). The hidden life of the basal ganglia: at the base of brain and mind. Cambridge: MIT press. ISBN   978-0-262-54311-8.
  3. "Israel Prize winners announced, among them Netanyahu critic Eyal Waldman". The Jerusalem Post | JPost.com. 2024-03-28. Retrieved 2024-07-14.
  4. Aziz, Morten L. Kringelbach, Tipu Z. (2008-12-01). "Sparking Recovery with Brain "Pacemakers"". Scientific American. Retrieved 2024-07-14.{{cite web}}: CS1 maint: multiple names: authors list (link)
  5. Shamah, David (7 March 2013). "The unsung Israeli hero of Parkinson's treatments".
  6. Taha, Alaa; Horn, Andreas (2023). "#33: Joachim Krauss, Marwan Hariz & Christian Moll – The History of Stereotactic and Functional Neurosurgery and Serendipity". Stimulating Brains: 83861058 Bytes. doi:10.6084/M9.FIGSHARE.22640266.
  7. Vedam-Mai, Vinata; Deisseroth, Karl; Giordano, James; Lazaro-Munoz, Gabriel; Chiong, Winston; Suthana, Nanthia; Langevin, Jean-Philippe; Gill, Jay; Goodman, Wayne; Provenza, Nicole R.; Halpern, Casey H.; Shivacharan, Rajat S.; Cunningham, Tricia N.; Sheth, Sameer A.; Pouratian, Nader (2021-04-19). "Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies". Frontiers in Human Neuroscience. 15. doi: 10.3389/fnhum.2021.644593 . ISSN   1662-5161. PMC   8092047 . PMID   33953663.
  8. Deuschl, Günther; Schade-Brittinger, Carmen; Krack, Paul; Volkmann, Jens; Schäfer, Helmut; Bötzel, Kai; Daniels, Christine; Deutschländer, Angela; Dillmann, Ulrich; Eisner, Wilhelm; Gruber, Doreen; Hamel, Wolfgang; Herzog, Jan; Hilker, Rüdiger; Klebe, Stephan (2006-08-31). "A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease". New England Journal of Medicine. 355 (9): 896–908. doi:10.1056/NEJMoa060281. ISSN   0028-4793. PMID   16943402.